Sign in
4

Changes in Ownership

ALNYLAM PHARMACEUTICALS, INC. Filed Acc 0001735276-24-000002

EVP, CLO & Secretary sold 1,591 shares at an average $170.99 ($272,050)

  • EVP, CLO & Secretary acquired 5,175 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Franchini Indrani Lall · EVP, CLO & Secretary

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-01 Exercise or conversion : show line 1 in the form +5,175 5,175 D
2024-02-02 Sale : show line 2 in the form −502 $170.01 $85,345 4,673 D
2024-02-02 Sale : show line 3 in the form −820 $171.14 $140,335 3,853 D
2024-02-02 Sale : show line 4 in the form −269 $172.38 $46,370 3,584 D
Open-market sales · 1,591 sh · avg $170.99 · $272,050

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2024-02-01 Exercise or conversion : show line 5 in the form Restricted Stock Units −5,175 5,175 5,175 D
Loading xslF345X05/edgardoc.xml…